FAQ

Pharmacogenomic testing is a personalized approach to medicine that examines your genetic makeup to understand how your genes influence your response to medications. It helps determine the most effective and safe medications for your unique genetic profile.

No problem. We can ship a PGx test anywhere in the United States and have initial and follow-up appointments via video conferencing.

Medication optimization involves fine-tuning your medication regimen based on your unique needs, genetic makeup, and health goals. It aims to maximize the benefits of your medications while minimizing potential side effects.

You may book a no-cost initial consultation here, so we can determine which service is best for you.

Pharmacogenomic testing involves analyzing specific genes related to drug metabolism and response. A sample of your DNA is collected by a simple cheek swab and sent to the lab. Results are received in 2-3 weeks.

Pharmacogenomic testing provides valuable insights into how your body processes medications. It can help avoid adverse reactions, reduce side effects, improve treatment outcomes, and enhance the overall effectiveness of your medication regimen.

You may click on this link to schedule an appointment.

We accept checks, cards, and health savings cards. There is a 4% fee for using a card.

We offer both physical and online meet-up options for your convenience. If you opt for an online session, you'll receive an email containing the video conferencing link, along with your confirmation email.

Yes, please do not eat, drink, or chew gum for 30 minutes prior to your test.

Medicare will cover part of your PGx service (usually $200) if you have qualifying medications and diagnoses. Please book an initial consultation and we will determine if you qualify for partial coverage.

Unfortunately, private insurance and ND Medicaid will not cover part/all of the service at this time.

No, the Pharmacogenomics test looks like a big Q-tip and is used to swab the inside of your mouth.

Pharmacogenomic testing is generally considered safe and non-invasive. It analyzes your DNA from a cheek swab. No needles and no blood! There are a few potential risks and considerations associated with pharmacogenomic testing:

• Privacy and Confidentiality: Since pharmacogenomic testing involves analyzing an individual's genetic information, there are concerns about the privacy and confidentiality of this sensitive data. Genetic information can reveal personal and familial details, and there's a risk that this information could be accessed or used in ways that individuals did not anticipate.

• Psychosocial Impact: The results of pharmacogenomic testing might reveal information about an individual's potential response to certain medications or their susceptibility to certain conditions. This information could have psychological and emotional implications for the individual and their family.

• Limited Data Interpretation: While there is a growing body of knowledge about genetic variations and drug responses, not all genetic markers have clear associations with specific medications or outcomes. In some cases, the clinical significance of certain genetic variations might not be well understood, leading to uncertainty in interpreting the results.

• Changing Clinical Decisions: It's important to remember that pharmacogenomic testing is just one tool among many that healthcare providers use to make treatment decisions. Relying solely on genetic information might not capture the full complexity of an individual's medical condition, and there's a risk of making treatment decisions solely based on genetic data.

• Unintended Consequences: Depending on the results of the testing, healthcare providers might change medication prescriptions or dosages. However, there's a possibility that altering medications based on genetic information could lead to unforeseen adverse effects or ineffective treatments.

• Limited Clinical Evidence: While pharmacogenomic testing has shown promise in some cases, there is still ongoing research to fully understand its clinical utility. The evidence supporting the use of genetic information to guide medication decisions might not be as robust for all drugs and conditions.
  

Before undergoing pharmacogenomic testing, individuals should have a discussion with their healthcare provider to weigh the potential benefits against the risks and consider their personal medical history, current medications, and health goals. As the field of pharmacogenomics continues to evolve, guidelines and best practices for testing and interpretation are likely to become more refined.

No. About 200 medications are included. If you are wondering if your specific medications would be included please schedule an initial consultation.

It usually takes 10-14 business days from the day the lab receives your test to get results.

All three options involve Pharmacogenomic testing. Side effect consultation also addresses challenges you may be facing with your current medications. Medication optimization also includes recommendations to optimize your entire medication regimen for better effectiveness and minimal side effects.

A side effect consultation is a personalized session with our experts to address any adverse effects or challenges you're experiencing with your current medications.

Deprescribing refers to the process of intentionally reducing or discontinuing medications that may no longer be necessary, beneficial, or may be causing harm to a patient. It is a systematic approach taken by healthcare professionals to review a patient's current medications and assess their ongoing appropriateness based on factors such as the patient's current health status, treatment goals, potential side effects, drug interactions, and the presence of other medical conditions.